You are here

P&T News

October 16

ALK-positive and ROS1-positive patients benefit
Application to FDA expected in early 2018
Senhance System aids surgeons in minimally invasive procedures
New indication follows study showing significant skin clearance at week 12

October 12

“Moonshot” goal: Spread success to patients in half the time
Siemens Magnetom Terra doubles available magnetic field strength

October 10

Company considering sale or spin-off of multibillion-dollar OTC business
When patients wrongly report drug allergies, doctors use inferior drugs, study finds
While restrictions are increasing, a third of plans impose none
“Unfortunate” outcome in phase 3 JUNIPER trial of abemaciclib
Investigational peptide vaccine induces attack on various cancers

October 9

One-time treatment eases pain for 12 weeks
Device targets moderate-to-severe central sleep apnea
Device billed as smallest, lightest responsive therapy for drug-resistant epilepsy
Potential new indication addresses EGFR mutation-positive NSCLC

October 6

Cobas Zika test is made by Roche Molecular Systems

October 5

New trial ordered in dispute between Amgen and Sanofi/Regeneron
Rapid testing approach may help speed effective treatment
First human trial shows progress toward preventing infections

October 4

Two formulations of MS drug earn Teva more than $4 billion